A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination

Vaccines against SARS-CoV-2 administered via the parenteral route (intra-muscular = i.m.) are effective at preventing COVID-19 in part by inducing neutralizing antibodies in the blood. The first line of defense against SARS-CoV-2 is in the upper respiratory tract, yet we know very little about whether COVID-19 vaccines induce immunity in this compartment, if at all. We analysed salivary antibodies against the SARS-CoV-2 Spike protein and its receptor binding domain (RBD) following 2 i.m. injections of either BNT162b2 or mRNA-1273 vaccines. Salivary anti-Spike/RBD IgG was detected after 1 dose and increased further after dose 2, reflecting the systemic immune response. Interestingly, salivary anti-Spike/RBD IgA associated with the secretory component (sIgA) was detected in nearly all vaccinated participants after one dose of mRNA vaccine, with anti-Spike sIgA diminishing after dose 2. Vaccination with ChAdOx1-S (Ad) followed by mRNA induced similar levels of salivary anti-Spike/RBD IgG and IgA, and both mRNA/mRNA and Ad/mRNA regimes provoked modest neutralizing capacity in this biofluid. Our results demonstrate that SARS-CoV-2 mRNA/mRNA and Ad/mRNA vaccination induces antibodies in the saliva, and in response to one dose of mRNA, a compartmentalized and transient antigen-specific sIgA response is generated that does not correlate with systemic immunity.

[1]  A. Gingras,et al.  Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers , 2021, medRxiv.

[2]  J. Münch,et al.  Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination , 2021, Nature Medicine.

[3]  A. Marchant,et al.  Immunological mechanisms of vaccine-induced protection against COVID-19 in humans , 2021, Nature Reviews Immunology.

[4]  B. Mustanski,et al.  COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men , 2021, The Journal of infectious diseases.

[5]  D. Walt,et al.  Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[7]  Daniel S. Chertow,et al.  SARS-CoV-2 infection of the oral cavity and saliva , 2021, Nature Medicine.

[8]  G. Debnath,et al.  Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva , 2021, bioRxiv.

[9]  H. Schuitemaker,et al.  Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine , 2021, The New England journal of medicine.

[10]  O. Schwartz,et al.  IgA dominates the early neutralizing antibody response to SARS-CoV-2 , 2020, Science Translational Medicine.

[11]  R. Baric,et al.  Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults , 2020, The New England journal of medicine.

[12]  D. Reich,et al.  Gut-educated IgA plasma cells defend the meningeal venous sinuses , 2020, Nature.

[13]  A. Bar-Or,et al.  Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 , 2019, Cell.

[14]  G. Alter,et al.  Sex differences in vaccine-induced humoral immunity , 2018, Seminars in Immunopathology.

[15]  R. Stocker,et al.  High-avidity IgA protects the intestine by enchaining growing bacteria , 2017, Nature.

[16]  Ping Zhang,et al.  Saliva in the diagnosis of diseases , 2016, International Journal of Oral Science.

[17]  D. Weissman,et al.  Antiviral Activities in Human Saliva , 2011, Advances in dental research.

[18]  R. Webby,et al.  Dynamic T cell migration program provides resident memory within intestinal epithelium , 2010, The Journal of experimental medicine.

[19]  J. Ebersole,et al.  Humoral immune responses in gingival crevice fluid: local and systemic implications. , 2003, Periodontology 2000.